Gyoung Min Kim1, Hyo-Cheol Kim2, Saebeom Hur3, Myungsu Lee3, Hwan Jun Jae3, Jin Wook Chung3. 1. Department of Radiology, Research Institute Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. 2. Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, # 101 Daehak-ro, Jongno-gu, Seoul, 110-744, Korea. angiointervention@gmail.com. 3. Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, # 101 Daehak-ro, Jongno-gu, Seoul, 110-744, Korea.
Abstract
PURPOSE: To describe the imaging findings and clinical course of sloughing of biliary tumour ingrowth of hepatocellular carcinoma (HCC) after chemoembolization. MATERIALS AND METHODS: We reviewed 12 patients who experienced sloughing of biliary tumour ingrowth after chemoembolization. We evaluated the patients' characteristics, clinical manifestations and treatment modalities. We also reviewed computed tomography (CT) scans to determine the characteristics of the sloughed tumour including length, attenuation and appearances during follow-up. RESULTS: The length of the sloughed tumour ranged from 0.6-7.8 cm. Their Hounsfield units ranged from 35-729. Sloughed tumours were misreported as biliary stones in four patients, and were not reported in the initial CT report in one patient. At the time of sloughing, seven patients complained of cholestatic symptoms, while the other five had no symptoms. Four patients underwent sphincterotomy and tumour removal under endoscopic retrograde cholangiopancreaticography (ERCP), two underwent percutaneous transhepatic biliary drainage (PTBD) and one underwent PTBD followed by ERCP. The remaining five were managed conservatively. Five sloughed tumours were removed by ERCP, six disappeared spontaneously within 3 months, and one patient had no follow-up image. CONCLUSIONS: Sloughing of biliary tumour ingrowth may be misinterpreted as biliary stone, and may or may not cause cholestatic symptoms. KEY POINTS: • Migration of intraductal tumour ingrowth of HCC after chemoembolization occurs more commonly than reported. • The sloughed tumour is often misinterpreted as biliary calculi. • It can make cholestasis and be managed by ERCP or PTBD. • In some asymptomatic cases, a wait-and-see approach can be taken.
PURPOSE: To describe the imaging findings and clinical course of sloughing of biliary tumour ingrowth of hepatocellular carcinoma (HCC) after chemoembolization. MATERIALS AND METHODS: We reviewed 12 patients who experienced sloughing of biliary tumour ingrowth after chemoembolization. We evaluated the patients' characteristics, clinical manifestations and treatment modalities. We also reviewed computed tomography (CT) scans to determine the characteristics of the sloughed tumour including length, attenuation and appearances during follow-up. RESULTS: The length of the sloughed tumour ranged from 0.6-7.8 cm. Their Hounsfield units ranged from 35-729. Sloughed tumours were misreported as biliary stones in four patients, and were not reported in the initial CT report in one patient. At the time of sloughing, seven patients complained of cholestatic symptoms, while the other five had no symptoms. Four patients underwent sphincterotomy and tumour removal under endoscopic retrograde cholangiopancreaticography (ERCP), two underwent percutaneous transhepatic biliary drainage (PTBD) and one underwent PTBD followed by ERCP. The remaining five were managed conservatively. Five sloughed tumours were removed by ERCP, six disappeared spontaneously within 3 months, and one patient had no follow-up image. CONCLUSIONS: Sloughing of biliary tumour ingrowth may be misinterpreted as biliary stone, and may or may not cause cholestatic symptoms. KEY POINTS: • Migration of intraductal tumour ingrowth of HCC after chemoembolization occurs more commonly than reported. • The sloughed tumour is often misinterpreted as biliary calculi. • It can make cholestasis and be managed by ERCP or PTBD. • In some asymptomatic cases, a wait-and-see approach can be taken.
Authors: S Satoh; I Ikai; G Honda; H Okabe; O Takeyama; Y Yamamoto; N Yamamoto; Y Iimuro; Y Shimahara; Y Yamaoka Journal: Surgery Date: 2000-11 Impact factor: 3.982